Nebenwirkungen · Vizimpro
Vizimpro 15 mg film-coated tablets Vizimpro 30 mg film-coated tablets Vizimpro 45 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10
HOS-141925 · Präparat HOS-098712
Skin-related adverse reactions Rash, erythematous and exfoliative skin condition adverse reactions were reported in 79.2% and 5.5%, respectively, of patients receiving Vizimpro. Skin-related adverse reactions were Grades 1 to 3. Grade 3 rash and erythematous skin condition adverse reactions were the most frequently reported Grade 3 adverse reactions (25.5%). Grade 3 exfoliative skin conditions were reported in 0.8% of patients (see section 4.4).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-12-17T10:45:00Z · SHA-256 6423421a559569edb50e690c7adfb2244dadfdef9ead0c56c0d6b33fb1c654f0 · Passage 7b5ee003c98c7f82b6237e408c62ba73f80b8ca93fd39c48f3978e1d734adb6e · Zeichen 11099–11548 im Abschnitt